Synopsys, Inc. $SNPS Shares Purchased by Bensler LLC

Bensler LLC raised its position in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 4.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,202 shares of the semiconductor company’s stock after acquiring an additional 634 shares during the quarter. Bensler LLC’s holdings in Synopsys were worth $7,281,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in SNPS. Brighton Jones LLC raised its holdings in shares of Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares in the last quarter. Valeo Financial Advisors LLC grew its stake in shares of Synopsys by 6.3% during the first quarter. Valeo Financial Advisors LLC now owns 570 shares of the semiconductor company’s stock worth $244,000 after purchasing an additional 34 shares in the last quarter. Linden Thomas Advisory Services LLC increased its holdings in Synopsys by 9.3% in the first quarter. Linden Thomas Advisory Services LLC now owns 1,407 shares of the semiconductor company’s stock valued at $603,000 after buying an additional 120 shares during the last quarter. Cornerstone Planning Group LLC raised its stake in Synopsys by 275.0% in the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 44 shares in the last quarter. Finally, Rehmann Capital Advisory Group raised its stake in Synopsys by 3.2% in the first quarter. Rehmann Capital Advisory Group now owns 1,327 shares of the semiconductor company’s stock valued at $569,000 after buying an additional 41 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling at Synopsys

In related news, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the transaction, the chief executive officer owned 71,615 shares of the company’s stock, valued at $42,181,951.15. This trade represents a 13.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the business’s stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the transaction, the chief accounting officer owned 20,520 shares in the company, valued at $10,278,468. This trade represents a 32.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 30,894 shares of company stock valued at $16,760,783. Company insiders own 0.62% of the company’s stock.

Synopsys Trading Down 0.7%

SNPS opened at $393.43 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The business’s 50 day moving average is $475.14 and its two-hundred day moving average is $514.16. The firm has a market cap of $73.08 billion, a price-to-earnings ratio of 30.88, a price-to-earnings-growth ratio of 5.02 and a beta of 1.10.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.75 by ($1.45). The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.77 billion. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business’s revenue was up 14.0% on a year-over-year basis. During the same quarter last year, the business posted $3.43 earnings per share. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, research analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Zacks Research cut Synopsys from a “hold” rating to a “strong sell” rating in a research report on Friday, September 12th. KeyCorp decreased their target price on Synopsys from $660.00 to $590.00 and set an “overweight” rating for the company in a research note on Wednesday, September 10th. BNP Paribas assumed coverage on shares of Synopsys in a research note on Thursday, October 2nd. They issued an “underperform” rating and a $425.00 price target on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Finally, Morgan Stanley lowered their target price on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a report on Thursday, September 11th. Ten equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $569.67.

Get Our Latest Stock Report on Synopsys

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.